CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like Zymeworks
Zymeworks logo

Zymeworks

zymeworks.com
Zymeworks is a royalty-driven biotechnology company that develops and manages a pipeline of novel, multifunctional biotherapeutics — including the approved antibody-drug conjugate Ziihera® (zanidatamab-hrii) and the candidate pasritamig — through in-house R&D and strategic partnerships.
MBRBBDLDASMKMESC
Zymeworks campaignconsultative3000 target
Companies like Zymeworks
“Zymeworks is a biotech company that develops biotherapeutics and generates royalty revenue — no outbound campaign angle applies to this record.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 5
Decision-makers 12
Emails 12
Signals 0

Companies like Zymeworks — competitors and alternatives

CompanyWhat they doLocationSizeHiring
Zymeworkszymeworks.com
MBRBBD
Zymeworks is a royalty-driven biotechnology company that develops and manages a pipeline of novel, multifunctional biotherapeutics
YZDBVS
Attovia is a clinical-stage biopharmaceutical company developing next-generation multispecific biologics for patients with high unSan Carlos, California51-200
Bicara Therapeuticsbicara.com
JSDMAW
Bicara Therapeutics is a clinical-stage biopharmaceutical company developing bifunctional therapies for patients with solid tumorsBoston, Massachusetts51-200
Biotech Value Advisorsbiotechvalue.com
DJMPCS
Biotech Value Advisors (BVA) is a commercialization advisory firm that delivers cross-functional commercial support to developing Radnor, Pennsylvania51-200
DBV Technologiesdbv-technologies.com
DBV Technologies is a global clinical stage biopharmaceutical company developing epicutaneous immunotherapy (EPIT) using the VIASK
Run live for more

Agent activity

Done
$fetch_profilezymeworks.com
Found: Zymeworks
$analyze_identityzymeworks.com
Zymeworks is a royalty-driven biotechnology company that develops and manages a pipeline of novel, multifunctional biotherapeutics — including the approved antibody-drug conjugate
$search_companiescompanies like Zymeworks
24 companies
$search_peopledecision-makers

Frequently asked questions about Zymeworks

What does Zymeworks do?

Zymeworks is a royalty-driven biotechnology company that develops and manages a pipeline of novel, multifunctional biotherapeutics — including the approved antibody-drug conjugate Ziihera® (zanidatamab-hrii) and the candidate pasritamig — through in-house R&D and strategic partnerships.

Who are Zymeworks's competitors?

Companies like Zymeworks include Attovia, Bicara Therapeutics, Biotech Value Advisors, DBV Technologies. See the full list of 24 competitors and alternatives above.

Who are the decision-makers at Zymeworks?

Key decision-makers and buying contacts at Zymeworks are listed above, including leaders across executive, finance, sales and operations.